• EGFP mRNA m1Ψ: A Mechanistic Assay Framework

  2026-09-21

  EGFP mRNA m1Ψ can do more than report transfection: it can help separate delivery, translation, RNA stability, and cell-state effects. This article develops a causal assay framework for interpreting N1-methylpseudouridine EGFP mRNA experiments and connects it to recent cap-independent translation research.

• Clathrin-Mediated Entry of Type III Grass Carp Reovirus

  2026-09-20

  Wang et al. used pharmacological inhibitors, transmission electron microscopy, and real-time quantitative PCR to show that genotype III grass carp reovirus enters CIK cells through a dynamin-dependent, acidified clathrin-mediated endocytic route. The study provides a pathway-level framework for distinguishing viral entry mechanisms while highlighting the limits of interpreting inhibitor data as definitive molecular proof.

• AG-120 (Ivosidenib): From 2-HG to AML Biology

  2026-09-19

  AG-120 (Ivosidenib) is more than a mutant IDH1 inhibitor: it is a tool for connecting 2-hydroxyglutarate reduction with differentiation, metabolic state, and assay interpretation. This article examines how CD44-dependent NADPH rewiring changes the way researchers evaluate AML mutant IDH1 treatment.

• Indole-3-pyruvic acid: Applied Research Workflows

  2026-09-18

  Indole-3-pyruvic acid connects auxin biosynthesis, fungal metabolism, and AhR-focused immune studies in one experimentally tractable metabolite. This guide converts pathway biology into practical workflows for flux analysis, PBMC assays, and troubleshooting, while separating established findings from optimization proposals.

• WNT5a/GSK3/β-Catenin Controls FAP Adipogenesis

  2026-09-18

  The reference study identifies the WNT5a/GSK3/β-catenin axis as a regulatory pathway that restrains adipogenic conversion of skeletal muscle fibro/adipogenic progenitors. By combining pharmacological inhibition, mass cytometry, animal models, network analysis, and transcriptomics, it connects FAP fate decisions with muscle regeneration and pathological fat accumulation.

• Oseltamivir acid: Reliable Assay Workflows

  2026-09-17

  This scenario-based guide explains how Oseltamivir acid (SKU A3689) can support reproducible influenza antiviral research and exploratory cell-viability studies. It covers mechanism, formulation, protocol controls, resistance interpretation, translational limitations, and practical supplier-selection criteria.

• CRL3ARMC5 and Integrator Control RNA Pol II

  2026-09-17

  Cacioppo et al. identify CRL3ARMC5 ubiquitin ligase and the Integrator complex as parallel quality-control pathways that regulate RNA polymerase II before productive elongation. Their findings show that RNA Pol II abundance alone is insufficient: cells must also prevent defective transcription complexes from entering gene bodies.

• Vacuolin-1: Lysosomal Exocytosis Inhibitor

  2026-09-16

  Vacuolin-1 is a cell-permeable lysosomal exocytosis inhibitor that blocks Ca2+-dependent lysosome–plasma membrane fusion. It provides a practical perturbation tool for lysosomal β-hexosaminidase release assays, membrane repair research, and studies of lysosome-mediated trafficking.

• Nystatin (Fungicidin) Research Workflows

  2026-09-16

  Build reproducible Candida susceptibility, adhesion, and membrane-perturbation assays with Nystatin (Fungicidin), while controlling the solubility and vehicle variables that can obscure polyene activity. The workflow also uses a Spiroplasma S2-cell study to show when Nystatin is informative as a negative pathway control rather than an antifungal treatment.

• TRIM66 and the One-Receptor Rule in Olfactory Neurons

  2026-09-15

  The reference study identifies TRIM66 as an epigenetic repressor that helps mature olfactory sensory neurons silence all but one olfactory receptor gene. Its loss preserves low-level expression of multiple receptors, disrupts olfactory neural activity, and impairs innate olfactory behaviors, linking enhancer repression to sensory circuit function.

• Calpeptin: A Calpain Inhibitor for Fibrosis Research

  2026-09-15

  Calpeptin is a potent calpain inhibitor with a reported 5 nM IC50 for human calpain 1. Product data support its use in pulmonary fibrosis research and fibrosis and inflammation modulation, while its effects remain limited to defined in vitro and mouse-model evidence.

• Triacetin and Aldehyde Formation in E-Cigarette Aerosols

  2026-09-14

  The 2018 ACS Omega study used 13C labeling and complementary NMR analyses to show that Triacetin hydrolysis generates acetic acid during aerosolization, promoting degradation of propylene glycol and glycerol. The resulting increase in formaldehyde hemiacetals, acrolein, and acetaldehyde shows why additive-driven aerosol chemistry should be evaluated separately from the safety of ingredients intended for ingestion.

• One-step TUNEL Cy3 Apoptosis Detection Kit Guide

  2026-09-14

  Turn DNA-break biology into actionable microscopy and flow-cytometry data across tissue sections and cultured cells. This guide combines practical TUNEL workflow design with safeguards for interpreting apoptosis signals in models that may also involve pyroptosis.

• Sodium Nitroprusside: A Sex-Aware Vascular Probe

  2026-09-13

  Sodium Nitroprusside is a nitric oxide donor that can separate vascular smooth muscle responses from upstream hormonal and autonomic effects. This article translates sex-dependent angiotensin II hypertension findings into a more rigorous framework for vascular assay design and interpretation.

• Low-Molecular-Weight Inhibitors of Complement

  2026-09-12

  The reference review explains how selective low-molecular-weight inhibitors of complement factor B and factor D can interrupt alternative-pathway amplification and support oral therapeutic development. Its main practical contribution is a translational framework connecting complement biochemistry, functional serum assays, disease models, and emerging clinical applications.

8615 records 1/575 page Next 12345 下5页 Last page